Mustafa Sengul
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Mustafa Sengul has a total of 84 co-authors. Here are the top co-authors by number of shared publications:
- Halime Sen Selim
Department of Obstetrics and Gynecology, Izmir Atatürk Research and Training Hospital, İzmir
3 shared publications - Kazım Kıratlı
Department of Infectious Diseases and Clinical Microbiology, Ataturk Training and Research Hospital, İzmir Katip Celebi University, İzmir, Türkiye
3 shared publications - Raziye Torun
Izmir City Hospital, Turkey
3 shared publications - Selin Acar
Dokuz Eylul University, Institute of Health Sciences, Izmir, Turkey
3 shared publications - Tijen Kaya Temiz
Department of Pharmacology and Toxicology Izmir Kâtip Celebi University Faculty of Medicine Izmir Türkiye
3 shared publications Baris Karadas
Department of Pharmacology, Faculty of Medicine, Izmir Katip Celebi University, Izmir, Turkey
2 shared publications
Latest Publications
- 3 September 2026
- Published by Georg Thieme Verlag KG in Zeitschrift für Geburtshilfe und Neonatologie
Uteroplacental Hemodynamics and Perinatal Outcomes in Maternal Hypothyroidism and Thyroid Autoimmunity: A Prospective Cohort Study
Maternal hypothyroidism and thyroid autoimmunity are frequently implicated in compromised uteroplacental perfusion and subsequent adverse perinatal outcomes. However, the incremental risk conferred by thyroid antibody positivity beyond that of hypothyroidism alone remains a subject of clinical debate To examine uteroplacental hemodynamics, via uterine artery (UtA) and umbilical artery (UA) Doppler, and their relation to perinatal outcomes in pregnancies complicated by hypothyroidism with or without thyroid antibodies. This prospective cohort study, conducted at a tertiary perinatology center between August 2024 and April 2025, enrolled 212 pregnant women (18–24 weeks’ gestation) into three groups: (1) hypothyroidism with thyroid antibodies [TPOAb/TGAb] on levothyroxine (n=72); (2) hypothyroidism without antibodies [first-trimester TSH>2.5 mIU/L] on levothyroxine (n=71); and (3) a control group (n=69). Standardized transabdominal UA and bilateral UtA Doppler assessments (S/D ratio, pulsatility index [PI]) were performed according to ISUOG guidelines. Comprehensive perinatal outcomes, including obstetric complications and neonatal status, were recorded. While BMI was significantly lower in the control group (p=0.008), fetal biometry and birth outcomes remained comparable across all cohorts. Paradoxically, mean UtA PI was significantly higher in controls than in both hypothyroid groups (p<0.001), whereas other Doppler parameters showed no significant differences. The overall obstetric complication rate was 41%, with no statistical variation between groups (p=0.999). Similarly, NICU admission and congenital hypothyroidism rates did not differ significantly. In this treated, single-center cohort, well-managed maternal hypothyroidism and thyroid autoimmunity were not associated with increased uteroplacental Doppler abnormalities or worse perinatal outcomes compared to controls. These findings suggest that timely and appropriate levothyroxine therapy may successfully mitigate the potential adverse hemodynamic impacts of thyroid dysfunction, though larger multicenter trials are needed to isolate the specific role of autoimmunity.
- 3 September 2026
- Published by Georg Thieme Verlag KG in Zeitschrift für Geburtshilfe und Neonatologie
Uteroplacental Hemodynamics and Perinatal Outcomes in Maternal Hypothyroidism and Thyroid Autoimmunity: A Prospective Cohort Study
Maternal hypothyroidism and thyroid autoimmunity are frequently implicated in compromised uteroplacental perfusion and subsequent adverse perinatal outcomes. However, the incremental risk conferred by thyroid antibody positivity beyond that of hypothyroidism alone remains a subject of clinical debate To examine uteroplacental hemodynamics, via uterine artery (UtA) and umbilical artery (UA) Doppler, and their relation to perinatal outcomes in pregnancies complicated by hypothyroidism with or without thyroid antibodies. This prospective cohort study, conducted at a tertiary perinatology center between August 2024 and April 2025, enrolled 212 pregnant women (18–24 weeks’ gestation) into three groups: (1) hypothyroidism with thyroid antibodies [TPOAb/TGAb] on levothyroxine (n=72); (2) hypothyroidism without antibodies [first-trimester TSH>2.5 mIU/L] on levothyroxine (n=71); and (3) a control group (n=69). Standardized transabdominal UA and bilateral UtA Doppler assessments (S/D ratio, pulsatility index [PI]) were performed according to ISUOG guidelines. Comprehensive perinatal outcomes, including obstetric complications and neonatal status, were recorded. While BMI was significantly lower in the control group (p=0.008), fetal biometry and birth outcomes remained comparable across all cohorts. Paradoxically, mean UtA PI was significantly higher in controls than in both hypothyroid groups (p<0.001), whereas other Doppler parameters showed no significant differences. The overall obstetric complication rate was 41%, with no statistical variation between groups (p=0.999). Similarly, NICU admission and congenital hypothyroidism rates did not differ significantly. In this treated, single-center cohort, well-managed maternal hypothyroidism and thyroid autoimmunity were not associated with increased uteroplacental Doppler abnormalities or worse perinatal outcomes compared to controls. These findings suggest that timely and appropriate levothyroxine therapy may successfully mitigate the potential adverse hemodynamic impacts of thyroid dysfunction, though larger multicenter trials are needed to isolate the specific role of autoimmunity.
- Open Access
- 8 May 2026
- Published by IMR Press in Clinical and Experimental Obstetrics & Gynecology
- Vol. 53 (5)
Evaluation of the Relationship Between Intrahepatic Cholestasis of Pregnancy and Serum Vitamin D, Folate, and Vitamin B12 Levels
Background: Intrahepatic cholestasis of pregnancy (ICP) is a pregnancy-related liver disease that occurs during the third trimester. Both maternal and fetal complications are common in pregnant women with cholestasis. The risk and severity of complications increase with higher serum bile acid levels. 25-hydroxycholecalciferol [25(OH)D3], folate, and vitamin B12 supplementation during pregnancy improves maternal and fetal outcomes. This study aimed to evaluate the association between serum 25(OH)D3, folate, and vitamin B12 levels in pregnant women with and without ICP. Data from 29 pregnant women diagnosed with ICP and 85 healthy pregnant women admitted to Izmir Atatürk Training and Research Hospital were compared. Methods: Izmir Atatürk Training and Research Hospital’s electronic data record system was reviewed retrospectively, and vitamin D, folate, and vitamin B12 levels, which are routinely screened during pregnancy, were determined for both groups. Results: Contrary to previous studies, no significant differences were found between the serum vitamin D, folate, or vitamin B12 levels between pregnant women with ICP and healthy pregnant women. These values, except for folate, were below the reference range in both groups. Conclusions: Limited access to a healthy and balanced diet in our country, irregular use of vitamin supplements, and seasonal conditions may have influenced our results.
- 8 May 2026
- Published by IMR Press in Clinical and Experimental Obstetrics & Gynecology
- Vol. 53 (5)
Open AccessEvaluation of the Relationship Between Intrahepatic Cholestasis of Pregnancy and Serum Vitamin D, Folate, and Vitamin B12 Levels
Background: Intrahepatic cholestasis of pregnancy (ICP) is a pregnancy-related liver disease that occurs during the third trimester. Both maternal and fetal complications are common in pregnant women with cholestasis. The risk and severity of complications increase with higher serum bile acid levels. 25-hydroxycholecalciferol [25(OH)D3], folate, and vitamin B12 supplementation during pregnancy improves maternal and fetal outcomes. This study aimed to evaluate the association between serum 25(OH)D3, folate, and vitamin B12 levels in pregnant women with and without ICP. Data from 29 pregnant women diagnosed with ICP and 85 healthy pregnant women admitted to Izmir Atatürk Training and Research Hospital were compared. Methods: Izmir Atatürk Training and Research Hospital’s electronic data record system was reviewed retrospectively, and vitamin D, folate, and vitamin B12 levels, which are routinely screened during pregnancy, were determined for both groups. Results: Contrary to previous studies, no significant differences were found between the serum vitamin D, folate, or vitamin B12 levels between pregnant women with ICP and healthy pregnant women. These values, except for folate, were below the reference range in both groups. Conclusions: Limited access to a healthy and balanced diet in our country, irregular use of vitamin supplements, and seasonal conditions may have influenced our results.
- 5 November 2025
- Published by Elsevier in Advances in Medical Sciences
- Vol. 70 (2) , 427-435
In vitro effects of transient receptor potential channel modulators on human tuba smooth muscle
- 5 November 2025
- Published by Elsevier in Advances in Medical Sciences
- Vol. 70 (2) , 427-435
In vitro effects of transient receptor potential channel modulators on human tuba smooth muscle
- 25 September 2025
- Published by Family Practice and Palliative Care in Family Practice and Palliative Care
- Vol. 10 (3) , 105-110
Pregnant women’s awareness about pelvic floor dysfunction and preventing strategies
Introduction: The aim of the study is to determine the knowledge of pregnant women about pelvic floor dysfunction and their awareness of the pelvic floor dysfunction (PFD) preventive effect of pelvic floor muscle exercises. Methods: This cross-sectional study was conducted on pregnant women in their third trimester who applied to Izmir Atatürk Research and Training Hospital Birth Unit between April and May 2022. A questionnaire was used in data collection. A total of 32 questions were asked to the 90 participants in order to evaluate their knowledge about urinary incontinence(UI), pelvic organ prolapse(POP) and fecal incontinence(FI). Correlation between knowledge about pelvic floor dysfunction and related factors such as age, number of pregnancies, educational status, occupation and economic status were evaluated. Results: It was determined that the level of knowledge about urinary incontinence was significantly higher than FI, and the awareness about POP was similar to the other two subgroups. The knowledge of the participants about the therapeutic-protective effect of pelvic floor muscle exercises (PFMT) for UI, POP and FI were determined as 65.5%, 41.4% and 27.6% respectively. It was determined those with higher educational level had a significantly more knowledge about POP being a treatable disease then the others. There was no significant difference between the groups in other parameters. Conclusions: Awareness of pregnant women’s about pelvic floor dysfunction and knowledge about protective effect of pelvic floor muscle exercises from PFD are insufficient. Effects of pelvic floor muscle exercises for protection of the pelvic floor should be underlined in antenatal classes and pregnant women encourage to practice pelvic floor muscle exercises in order to prevent PFD.
- 25 September 2025
- Published by Family Practice and Palliative Care in Family Practice and Palliative Care
- Vol. 10 (3) , 105-110
Pregnant women’s awareness about pelvic floor dysfunction and preventing strategies
Introduction: The aim of the study is to determine the knowledge of pregnant women about pelvic floor dysfunction and their awareness of the pelvic floor dysfunction (PFD) preventive effect of pelvic floor muscle exercises. Methods: This cross-sectional study was conducted on pregnant women in their third trimester who applied to Izmir Atatürk Research and Training Hospital Birth Unit between April and May 2022. A questionnaire was used in data collection. A total of 32 questions were asked to the 90 participants in order to evaluate their knowledge about urinary incontinence(UI), pelvic organ prolapse(POP) and fecal incontinence(FI). Correlation between knowledge about pelvic floor dysfunction and related factors such as age, number of pregnancies, educational status, occupation and economic status were evaluated. Results: It was determined that the level of knowledge about urinary incontinence was significantly higher than FI, and the awareness about POP was similar to the other two subgroups. The knowledge of the participants about the therapeutic-protective effect of pelvic floor muscle exercises (PFMT) for UI, POP and FI were determined as 65.5%, 41.4% and 27.6% respectively. It was determined those with higher educational level had a significantly more knowledge about POP being a treatable disease then the others. There was no significant difference between the groups in other parameters. Conclusions: Awareness of pregnant women’s about pelvic floor dysfunction and knowledge about protective effect of pelvic floor muscle exercises from PFD are insufficient. Effects of pelvic floor muscle exercises for protection of the pelvic floor should be underlined in antenatal classes and pregnant women encourage to practice pelvic floor muscle exercises in order to prevent PFD.
- Open Access
- 26 May 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (11) , 3718
Comparison of Maternal Serum Neuropilin-1 (NRP-1) and Fetal Cord Blood NRP-1 Concentrations in Between Normotensive Pregnant Women and Those with Preeclampsia
Background: The aim of this study was to compare the levels of Neuropilin-1 (NRP-1) in maternal plasma and fetal cord blood plasma between pregnancies complicated by preeclampsia (PE) and those in normotensive pregnant women. Materials and Methods: This prospectively designed study included 53 pregnant women aged 18 years or older and at least 20 weeks into gestation, who were admitted to the Maternity Department of Izmir Katip Çelebi University Atatürk Training and Research Hospital. The patient group consisted of 28 pregnant women who met the diagnostic criteria for PE, while the control group included 25 normotensive pregnant women. The diagnosis of PE was established based on the 2020 diagnostic criteria of the American College of Obstetricians and Gynecologists (ACOG). After detailed anamnesis, blood samples were collected immediately after delivery in EDTA tubes to assess serum NRP-1 levels. These samples included maternal blood, fetal cord blood, and additional tests such as CBC, liver and kidney function tests, serum electrolytes, spot urinalysis, prothrombin time (PT), and activated partial thromboplastin time (APTT). Results: There was a statistically significant difference between the two groups in terms of gestational week, presence of comorbidities, hypertension (HT), diabetes mellitus (DM), history of PE, and protein detected in spot urine examinations. Pregnant women in the PE group had significantly higher rates of comorbidities, HT, and DM compared to the control group (p < 0.001, 0.002, and 0.007, respectively). No statistically significant differences were observed between the two groups regarding hemoglobin, platelet count, aspartate aminotransferase (AST), alanine aminotransferase (ALT), or fetal cord plasma NRP-1 levels (p: 0.736, 0.831, 0.561, and 0.734, respectively). However, a statistically significant difference was found in maternal plasma NRP-1 levels (p: 0.02), which were lower in the control group compared to the PE group (median: 473.3 pg/mL vs. 587.7 pg/mL, respectively). The optimal cut-off value for maternal plasma NRP-1 to predict PE, with the best sensitivity and specificity, was determined to be 358.4 pg/mL. Among the study participants, 40 pregnant women had maternal plasma NRP-1 levels above the cut-off value, while 13 had levels below it. PE occurred significantly more frequently in the high NRP-1 group than in the low group. When demographic and clinical characteristics were analyzed, a statistically significant but weak positive correlation was found between body mass index (BMI) and maternal plasma NRP-1 levels (p: 0.02, Rho: 0.304). No strong or statistically significant relationships were identified with other variables. There was no significant difference in fetal cord plasma NRP-1 levels between the PE group and the normotensive group. In contrast, maternal plasma NRP-1 levels were significantly higher in the PE group. The cut-off value for maternal plasma NRP-1, providing optimal sensitivity and specificity for predicting PE, remained 358.4 pg/mL. Conclusions: While further studies involving larger cohorts of pregnant women from diverse racial backgrounds and various hospitals are needed to better understand the relationship between NRP-1 and PE, maternal NRP-1 concentration shows promise as a diagnostic marker.
- 26 May 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (11) , 3718
Open AccessComparison of Maternal Serum Neuropilin-1 (NRP-1) and Fetal Cord Blood NRP-1 Concentrations in Between Normotensive Pregnant Women and Those with Preeclampsia
Background: The aim of this study was to compare the levels of Neuropilin-1 (NRP-1) in maternal plasma and fetal cord blood plasma between pregnancies complicated by preeclampsia (PE) and those in normotensive pregnant women. Materials and Methods: This prospectively designed study included 53 pregnant women aged 18 years or older and at least 20 weeks into gestation, who were admitted to the Maternity Department of Izmir Katip Çelebi University Atatürk Training and Research Hospital. The patient group consisted of 28 pregnant women who met the diagnostic criteria for PE, while the control group included 25 normotensive pregnant women. The diagnosis of PE was established based on the 2020 diagnostic criteria of the American College of Obstetricians and Gynecologists (ACOG). After detailed anamnesis, blood samples were collected immediately after delivery in EDTA tubes to assess serum NRP-1 levels. These samples included maternal blood, fetal cord blood, and additional tests such as CBC, liver and kidney function tests, serum electrolytes, spot urinalysis, prothrombin time (PT), and activated partial thromboplastin time (APTT). Results: There was a statistically significant difference between the two groups in terms of gestational week, presence of comorbidities, hypertension (HT), diabetes mellitus (DM), history of PE, and protein detected in spot urine examinations. Pregnant women in the PE group had significantly higher rates of comorbidities, HT, and DM compared to the control group (p < 0.001, 0.002, and 0.007, respectively). No statistically significant differences were observed between the two groups regarding hemoglobin, platelet count, aspartate aminotransferase (AST), alanine aminotransferase (ALT), or fetal cord plasma NRP-1 levels (p: 0.736, 0.831, 0.561, and 0.734, respectively). However, a statistically significant difference was found in maternal plasma NRP-1 levels (p: 0.02), which were lower in the control group compared to the PE group (median: 473.3 pg/mL vs. 587.7 pg/mL, respectively). The optimal cut-off value for maternal plasma NRP-1 to predict PE, with the best sensitivity and specificity, was determined to be 358.4 pg/mL. Among the study participants, 40 pregnant women had maternal plasma NRP-1 levels above the cut-off value, while 13 had levels below it. PE occurred significantly more frequently in the high NRP-1 group than in the low group. When demographic and clinical characteristics were analyzed, a statistically significant but weak positive correlation was found between body mass index (BMI) and maternal plasma NRP-1 levels (p: 0.02, Rho: 0.304). No strong or statistically significant relationships were identified with other variables. There was no significant difference in fetal cord plasma NRP-1 levels between the PE group and the normotensive group. In contrast, maternal plasma NRP-1 levels were significantly higher in the PE group. The cut-off value for maternal plasma NRP-1, providing optimal sensitivity and specificity for predicting PE, remained 358.4 pg/mL. Conclusions: While further studies involving larger cohorts of pregnant women from diverse racial backgrounds and various hospitals are needed to better understand the relationship between NRP-1 and PE, maternal NRP-1 concentration shows promise as a diagnostic marker.
- Open Access
- 24 March 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (7) , 2204
Evaluation of the Fetal Brain in Maternal Hypothyroidism and Thyroid Autoantibody Positivity: A Prospective Case-Control Study
Background/Objectives: Maternal thyroid function plays a crucial role in fetal brain development, yet the potential impact of maternal hypothyroidism and thyroid autoimmunity on fetal intracranial structures remains inadequately explored. To investigate the impact of maternal hypothyroidism and thyroid autoimmunity on fetal intracranial structures, focusing on potential alterations in critical brain parameters during mid-gestation. Methods: This prospective case-control study included pregnant women between 18 and 24 weeks of gestation. Participants were divided into three groups: hypothyroidism and antibodies (Ab) group, hypothyroidism and Ab(–) group, and the control group. Ultrasonographic measurements of fetal intracranial structures such as the posterior lateral ventricle (PLV), cavum septum pellucidi (CSP), cisterna magna (CM), thalamus, and transcerebellar diameter (TCD) were recorded and compared. Results: A total of 153 pregnant women were evaluated (n = 52 in the hypothyroidism and Ab(+) group, n = 51 in the hypothyroidism and Ab(−) group, and n = 50 in the control group). Although most of the biometric parameters were similar across the groups, the hypothyroidism and Ab(+) group exhibited significantly lower PLV and thalamus measurements compared to the control group (p < 0.05). Additionally, there was a notable difference in the BMI among the groups, with hypothyroid participants (with or without antibodies) showing higher rates of being overweight or obese. Conclusions: Maternal hypothyroidism and the presence of thyroid autoantibodies may be associated with subtle changes in fetal brain structures during the mid-gestation period, particularly in the thalamus and PLV.
- 24 March 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (7) , 2204
Open AccessEvaluation of the Fetal Brain in Maternal Hypothyroidism and Thyroid Autoantibody Positivity: A Prospective Case-Control Study
Background/Objectives: Maternal thyroid function plays a crucial role in fetal brain development, yet the potential impact of maternal hypothyroidism and thyroid autoimmunity on fetal intracranial structures remains inadequately explored. To investigate the impact of maternal hypothyroidism and thyroid autoimmunity on fetal intracranial structures, focusing on potential alterations in critical brain parameters during mid-gestation. Methods: This prospective case-control study included pregnant women between 18 and 24 weeks of gestation. Participants were divided into three groups: hypothyroidism and antibodies (Ab) group, hypothyroidism and Ab(–) group, and the control group. Ultrasonographic measurements of fetal intracranial structures such as the posterior lateral ventricle (PLV), cavum septum pellucidi (CSP), cisterna magna (CM), thalamus, and transcerebellar diameter (TCD) were recorded and compared. Results: A total of 153 pregnant women were evaluated (n = 52 in the hypothyroidism and Ab(+) group, n = 51 in the hypothyroidism and Ab(−) group, and n = 50 in the control group). Although most of the biometric parameters were similar across the groups, the hypothyroidism and Ab(+) group exhibited significantly lower PLV and thalamus measurements compared to the control group (p < 0.05). Additionally, there was a notable difference in the BMI among the groups, with hypothyroid participants (with or without antibodies) showing higher rates of being overweight or obese. Conclusions: Maternal hypothyroidism and the presence of thyroid autoantibodies may be associated with subtle changes in fetal brain structures during the mid-gestation period, particularly in the thalamus and PLV.
- Open Access
- 27 May 2024
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 135 (2) , 173-179
In vitro effect of hyoscine‐N‐butyl bromide and diclofenac sodium in human tuba uterina
Introduction: To investigate the in vitro effect of diclofenac on tubal smooth muscle as an alternative to hyoscine‐N‐butyl bromide, which is used for premedication before hysterosalpingography (HSG).Material and Methods: Fallopian tubes were retrieved from seven healthy women after bilateral tubal ligation and in vitro contractility and histological studies were conducted using tissue bath and immunohistochemistry.Results: Diclofenac sodium and hyoscine‐N‐butyl bromide did not significantly change the basal mean tension; however, they decreased the contractions induced by potassium chloride (KCl). The relaxant effect of diclofenac sodium and hyoscine‐N‐butyl bromide was not statistically significantly different. The presence of cyclooxygenase (COX)‐2 enzyme in the fallopian tube was demonstrated by immunohistochemical studies.Conclusions: The in vitro relaxant effect of diclofenac sodium on the fallopian tube is similar to hyoscine‐N‐butyl bromide. Diclofenac may have the potential to be used as an alternative to hyoscine‐N‐butyl bromide in premedication in HSG.
- 27 May 2024
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 135 (2) , 173-179
Open AccessIn vitro effect of hyoscine‐N‐butyl bromide and diclofenac sodium in human tuba uterina
Introduction: To investigate the in vitro effect of diclofenac on tubal smooth muscle as an alternative to hyoscine‐N‐butyl bromide, which is used for premedication before hysterosalpingography (HSG).Material and Methods: Fallopian tubes were retrieved from seven healthy women after bilateral tubal ligation and in vitro contractility and histological studies were conducted using tissue bath and immunohistochemistry.Results: Diclofenac sodium and hyoscine‐N‐butyl bromide did not significantly change the basal mean tension; however, they decreased the contractions induced by potassium chloride (KCl). The relaxant effect of diclofenac sodium and hyoscine‐N‐butyl bromide was not statistically significantly different. The presence of cyclooxygenase (COX)‐2 enzyme in the fallopian tube was demonstrated by immunohistochemical studies.Conclusions: The in vitro relaxant effect of diclofenac sodium on the fallopian tube is similar to hyoscine‐N‐butyl bromide. Diclofenac may have the potential to be used as an alternative to hyoscine‐N‐butyl bromide in premedication in HSG.
- Open Access
- 25 March 2024
- Published by Family Practice and Palliative Care in Family Practice and Palliative Care
- Vol. 9 (1) , 8-13
A public health problem in pregnant women: acute toxoplasma infection - a retrospective study of 12 years of data from a training and research hospital in Izmir
Introduction: The aim of this study is to identify the prevalence of acute toxoplasmosis in pregnant patients who are monitored in our hospital and to provide insight into screening and management options by assessing maternal and fetal outcomes. Methods: Pregnants between the ages of 18-49, who were followed up in the Gynecology and Obstetrics Polyclinic/Clinic and Infectious Diseases Polyclinic/Clinic of a Training and Research Hospital between January 1, 2010 and December 31, 2021, were included in this study. T. gondii IgM, IgG and avidity tests which were performed for pregnant women were evaluated retrospectively. Results: The study consisted of 7480 pregnants. Three hundred eighty-six (%5.16) of the pregnant women tested positive. Anti-T. gondii IgM seropositivity was found to be most common in the 18-28 age group (7.82%), and this frequency gradually decreased as age progressed. Two of the 122 patients whose polymerase chain reaction for T. gondii was examined from amniotic fluid at the outer center had congenital toxoplasmosis, and these pregnancies were terminated. Conclusions: Pregnant women continue to have a considerable risk of developing acute toxoplasmosis. For this infestation, which still remains on the agenda as a public health problem, every individual who is planning a pregnancy and has not had a serological test before should be screened before pregnancy. Pregnant women should continue to be informed and educated about this parasite, in our opinion.
- 25 March 2024
- Published by Family Practice and Palliative Care in Family Practice and Palliative Care
- Vol. 9 (1) , 8-13
Open AccessA public health problem in pregnant women: acute toxoplasma infection - a retrospective study of 12 years of data from a training and research hospital in Izmir
Introduction: The aim of this study is to identify the prevalence of acute toxoplasmosis in pregnant patients who are monitored in our hospital and to provide insight into screening and management options by assessing maternal and fetal outcomes. Methods: Pregnants between the ages of 18-49, who were followed up in the Gynecology and Obstetrics Polyclinic/Clinic and Infectious Diseases Polyclinic/Clinic of a Training and Research Hospital between January 1, 2010 and December 31, 2021, were included in this study. T. gondii IgM, IgG and avidity tests which were performed for pregnant women were evaluated retrospectively. Results: The study consisted of 7480 pregnants. Three hundred eighty-six (%5.16) of the pregnant women tested positive. Anti-T. gondii IgM seropositivity was found to be most common in the 18-28 age group (7.82%), and this frequency gradually decreased as age progressed. Two of the 122 patients whose polymerase chain reaction for T. gondii was examined from amniotic fluid at the outer center had congenital toxoplasmosis, and these pregnancies were terminated. Conclusions: Pregnant women continue to have a considerable risk of developing acute toxoplasmosis. For this infestation, which still remains on the agenda as a public health problem, every individual who is planning a pregnancy and has not had a serological test before should be screened before pregnancy. Pregnant women should continue to be informed and educated about this parasite, in our opinion.
- Open Access
- 10 January 2024
- Published by Balikesir Medical Journal in Balıkesir Medical Journal
- Vol. 7 (3) , 104-116
Does COVID-19 infection pose a risk to women of childbearing age?
Objectives: This study aims to investigate the potential differential impact of COVID-19 infection on pregnant women compared to non-pregnant individuals of childbearing age by evaluating laboratory findings from both inpatient and outpatient cases. Material and Methods: From the onset of COVID-19 in Turkey in March 2020 until the commencement of vaccination, a total of 94 COVID-19 patients were included in three separate groups: pregnant women and non-pregnant individuals with COVID-19 (with and without pneumonia). Sociodemographic data and examination findings were retrospectively retrieved from the hospital information system. Results: The study revealed that pregnant women, with a mean age of 28.87±1.38, experienced a significantly shorter mean length of hospital stay of 5.03±0.49 days compared to the other groups (p<0.001). Notably, pregnant women exhibited significant variations in urea, creatinine, white blood cell count, neutrophil count, hemoglobin, and hematocrit values in comparison to the other groups (p<0.001). Moreover, there were significant differences among the three groups concerning neutrophil and lymphocyte percentage values (p<0.001). Conclusion: The study suggests that COVID-19 infection in pregnant women is associated with more favorable clinical outcomes, shorter length of hospital stay, and relatively moderate alterations in laboratory findings when accounting for pregnancy-induced changes. It is implied that pregnancy might not pose as substantial a risk factor for severe COVID-19 infection as advanced age or underlying chronic conditions such as diabetes, asthma, COPD, and malignancy.
- 10 January 2024
- Published by Balikesir Medical Journal in Balıkesir Medical Journal
- Vol. 7 (3) , 104-116
Open AccessDoes COVID-19 infection pose a risk to women of childbearing age?
Objectives: This study aims to investigate the potential differential impact of COVID-19 infection on pregnant women compared to non-pregnant individuals of childbearing age by evaluating laboratory findings from both inpatient and outpatient cases. Material and Methods: From the onset of COVID-19 in Turkey in March 2020 until the commencement of vaccination, a total of 94 COVID-19 patients were included in three separate groups: pregnant women and non-pregnant individuals with COVID-19 (with and without pneumonia). Sociodemographic data and examination findings were retrospectively retrieved from the hospital information system. Results: The study revealed that pregnant women, with a mean age of 28.87±1.38, experienced a significantly shorter mean length of hospital stay of 5.03±0.49 days compared to the other groups (p<0.001). Notably, pregnant women exhibited significant variations in urea, creatinine, white blood cell count, neutrophil count, hemoglobin, and hematocrit values in comparison to the other groups (p<0.001). Moreover, there were significant differences among the three groups concerning neutrophil and lymphocyte percentage values (p<0.001). Conclusion: The study suggests that COVID-19 infection in pregnant women is associated with more favorable clinical outcomes, shorter length of hospital stay, and relatively moderate alterations in laboratory findings when accounting for pregnancy-induced changes. It is implied that pregnancy might not pose as substantial a risk factor for severe COVID-19 infection as advanced age or underlying chronic conditions such as diabetes, asthma, COPD, and malignancy.